Cargando…
The evolution of survival of pulmonary arterial hypertension over 15 years
The prognosis of pulmonary arterial hypertension (PAH) remains dismal. Over the years, multiple therapeutic advances have been introduced. This study evaluates the evolution of PAH survival over the past 15 years. We included 293 consecutive adult patients diagnosed with PAH between 2005 and 2019 (m...
Autores principales: | Hendriks, Paul M., Staal, Diederik P., van de Groep, Liza D., van den Toorn, Leon M., Chandoesing, Prewesh P., Kauling, Robert M., Mager, Hans‐Jurgen, van den Bosch, Annemien E., Post, Marco C., Boomars, Karin A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579738/ https://www.ncbi.nlm.nih.gov/pubmed/36268054 http://dx.doi.org/10.1002/pul2.12137 |
Ejemplares similares
-
Peripheral Blood T Cells of Patients with IPAH Have a Reduced Cytokine-Producing Capacity
por: van Uden, Denise, et al.
Publicado: (2022) -
Sexual function is impaired in women and men with pulmonary hypertension
por: Hendriks, Paul M., et al.
Publicado: (2023) -
Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension
por: Heukels, Peter, et al.
Publicado: (2021) -
The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension
por: Geenen, Laurie W., et al.
Publicado: (2019) -
Plasma markers in pulmonary hypertension subgroups correlate with patient survival
por: Koudstaal, T., et al.
Publicado: (2021)